Newsroom

Extra! Extra!
Read all about it

Welcome to our Newsroom, your go-to source for the latest updates on Galapagos. Explore press releases, insightful blogs, and access our resource hub, complete with company materials, designed to provide media and journalists with comprehensive information about our company’s innovations and milestones

Press releasesDownload Center

The latest

Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S.

Catalent announced a strategic collaboration with Galapagos to support decentralized manufacturing for clinical studies of GLPG5101, Galapagos’ investigational CAR-T therapy for relapsed/refractory non-Hodgkin lymphoma (NHL) indications. Catalent will support manufacturing for Galapagos’ upcoming trials in New Jersey, New York, and surrounding areas.

Read more

The latest

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos NV today announced a planned separation into two entities: a newly to be formed company (to be named at a later date, herein “SpinCo”), which would focus on building a pipeline of innovative medicines through transformational transactions, and Galapagos, which would continue to advance its global cell therapy leadership in addressing high unmet medical needs in oncology.

Read more

The latest

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Galapagos today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 pm PT in San Francisco.

Read more

STORIES

Press releases

View All Press Releases

Follow our journey

Subscribe to receive our press releases

Do you want to stay up to date on our journey, as we are pioneering for patients?

Subscribe to our press releasesContact Media Relations